March 17 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :* HEALTH CANADA APPROVES NEW INDICATION FOR LUNG CANCER TREATMENT OPTION ALUNBRIG®* TAKEDA CANADA INC. - HEALTH CANADA...
Investing.com – Japan equities were lower at the close on Wednesday, as losses in the Paper & Pulp, Railway & Bus and Real Estate sectors propelled shares lower. At the close in...
Jan 19 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :* TAKEDA CANADA - APPROVAL BY HEALTH CANADA OF ENTYVIO IN READY-TO-USE SELF-INJECTABLE SUBCUTANEOUS FORMAT FOR AT-HOME...
Investing in international equities offers exposure to the growth of global industry titans and boosts portfolio diversification. One key concern: how moves in foreign exchange...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 8.23 | 8.69 | 8.19 | -0.32 | -3.74% | 87.45K | Toronto | |||
| 0.135 | 0.00 | 0.00 | +0.015 | +12.50% | 162.93K | CSE | |||
| 0.70 | 0.00 | 0.00 | +0.04 | +6.06% | 119.16K | CSE | |||
| 3.93 | 4.05 | 3.90 | -0.58 | -12.86% | 8.00K | Toronto | |||
| 0.20 | 0.00 | 0.00 | 0.0000 | 0.00% | 2.50K | CSE | |||
| 44.60 | 44.65 | 43.67 | +0.48 | +1.09% | 80.94K | Toronto | |||
| 2.45 | 2.60 | 2.44 | -0.10 | -3.92% | 13.17K | TSXV | |||
| 0.10 | 0.00 | 0.00 | 0.00 | 0.00% | 7.50K | CSE | |||
| 18.88 | 19.61 | 18.84 | -0.15 | -0.79% | 173.63K | Toronto | |||
| 61.65 | 61.87 | 60.88 | +0.38 | +0.62% | 536.23K | Toronto | |||
| 5.63 | 5.74 | 5.63 | -0.09 | -1.49% | 161.92K | Toronto | |||
| 3.91 | 4.00 | 3.86 | +0.02 | +0.51% | 308.55K | NEO | |||
| 63.84 | 64.28 | 63.27 | -0.19 | -0.30% | 370.85K | Toronto | |||
| 16.00 | 16.14 | 15.95 | -0.13 | -0.81% | 104.97K | Toronto | |||
| 25.03 | 25.50 | 24.75 | -0.47 | -1.84% | 1.58M | Toronto |
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.